Article

Cell-free DNA comparative analysis of genomic landscape of first-line hormone-receptor positive metastatic breast cancer from US and China

2021-05-17

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose</bold>: Comparison of mutation landscape across ethnics using the identical detecting platform is important. We explored the differential genomic landscape of patients with hormone-receptor positive (HR+), HER2-negative MBC of first line recurrence or Stage IV at diagnosis from the United States (US) and China (CN).<bold>Methods</bold>: Twenty-seven US patients and 65 CN p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 26b2fbe2-ede6-516c-9e84-73d6cc189927
DOI: 10.21203/rs.3.rs-120555/v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cell-free DNA comparative analysis of genomic landscape of first-line hormone-receptor positive metastatic breast cancer from US and ChinaDOI 10.21203/rs.3.rs-120555/v2Read

Circulating genomic landscape following cyclin-dependent kinase 4/6 inhibitors exposure in HR + /HER2− metastatic breast cancer: a retrospective multi-institutional Consortium analysisSemantic proximity Read

Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(-) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice.Semantic proximity Read

Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients.Semantic proximity Read

Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatmentsSemantic proximity Read

Genetic landscape and personalized tracking of tumor mutations in Vietnamese women with breast cancer.Semantic proximity Read

Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer PatientsSemantic proximity Read

[Exploratory study of circulating tumor DNA detection in early breast cancer: an analysis of 75 next-generation sequencing results].Semantic proximity Read

Circulating Tumor DNA Mutation Profiling Reveals Prognostic Signatures in Breast CancerSemantic proximity Read

Targeted deep sequencing revealed variants in cell-free DNA of hormone receptor-positive metastatic breast cancer patientsSemantic proximity Read

Serial Circulating Tumor DNA Identification Associated with the Efficacy and Prognosis of Neoadjuvant Chemotherapy in Breast CancerSemantic proximity Read

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer.Semantic proximity Read

Bridging the gap: ctDNA, genomics, and equity in breast cancer careSemantic proximity Read